Journal
ADVANCED MATERIALS
Volume 33, Issue 3, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202004559
Keywords
biopolymers; cancer immunotherapy; colorectal cancer; immune implants; postoperative management
Categories
Funding
- National Natural Science Foundation of China [51973215, 51673185, 52003268, 51829302, 51833010, 51520105004]
- Jilin Province Science and Technology Development Plan [20190103112JH]
- Youth Innovation Promotion Association of Chinese Academy of Sciences
Ask authors/readers for more resources
The biopolymer immune implant designed for post-surgical therapy of CRC shows promising results in eradicating residual tumors, inhibiting distal tumor growth, and eliciting immune memory effects, providing a valuable option for preventing tumor recurrence and metastasis.
Surgical resection is the first-line therapy for colorectal cancer (CRC). However, for advanced CRC, the curative effect of surgical resection is limited due to either local recurrence or distal metastasis. Postoperative in situ immunotherapy, presents a promising option for preventing tumor recurrence and metastasis, owing to the fact that surgeons have unique opportunities and direct access to the surgical site. Herein, a designed biopolymer immune implant for CRC post-surgical therapy, characterized with tissue adhesion, sustained drug release, and sequential elicitation of innate immunity, adaptive immunity, and immune memory effects, is reported. With gradual release of the loaded resiquimod (R848) and anti-OX40 antibody (aOX40), the immune implant can eradicate residual tumors post-surgery (with no tumor recurrence in 150 days), inhibit the growth of distal tumors and elicit immune memory effects to resist tumor re-challenge. Immunological analysis reveal that the biopolymer immune plant treatment leads to a two-stage action, with enhanced natural killer cells (NK cells) infiltration and activation of dendritic cells (DCs) in the first several days, then a greatly increased population of infiltrating T cells, and finally immune memory effects are established. The reported biopolymer immune implants provide a valuable and clinically-relevant option for post-surgical CRC management.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available